Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 4,039 |
| Receivables | 70 |
| TOTAL | $4,447 |
| Non-Current Assets | |
| PPE Net | 2,163 |
| Intangibles | 576 |
| Other Non-Current Assets | 129 |
| TOTAL | $2,868 |
| Total Assets | $7,315 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 563 |
| Accrued Expenses | 444 |
| TOTAL | $2,805 |
| Non-Current Liabilities | |
| Deferred Revenues | 1,798 |
| Other Non-Current Liabilities | 28,984 |
| TOTAL | $30,224 |
| Total Liabilities | $33,029 |
| Shareholders' Equity | |
| Retained earnings | -25,957 |
| TOTAL | $-25,714 |
| Total Liabilities And Equity | $7,315 |